MARC details
000 -LEADER |
fixed length control field |
05846cam a2200805 i 4500 |
001 - CONTROL NUMBER |
control field |
on1162041497 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220712101925.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION |
fixed length control field |
m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr ||||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
120312s2012 nyua ob 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2020679769 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
-- |
pn |
Transcribing agency |
DLC |
Modifying agency |
VLY |
-- |
OCLCO |
-- |
YDXCP |
-- |
E7B |
-- |
N$T |
-- |
OCLCF |
-- |
EBLCP |
-- |
DEBSZ |
-- |
AGLDB |
-- |
VTS |
-- |
AU@ |
-- |
STF |
-- |
K6U |
-- |
OCLCQ |
-- |
SNK |
-- |
OCLCO |
019 ## - |
-- |
837578466 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781620815885 |
Qualifying information |
(ebook) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
1620815885 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
9781620815601 |
Qualifying information |
(hardcover) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
Cancelled/invalid ISBN |
1620815605 |
Qualifying information |
(hardcover) |
029 1# - (OCLC) |
OCLC library identifier |
DEBBG |
System control number |
BV042795285 |
029 1# - (OCLC) |
OCLC library identifier |
DEBSZ |
System control number |
456602615 |
029 1# - (OCLC) |
OCLC library identifier |
DEBSZ |
System control number |
472782908 |
035 ## - SYSTEM CONTROL NUMBER |
System control number |
(OCoLC)1162041497 |
Canceled/invalid control number |
(OCoLC)837578466 |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
050 00 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
QR186.82 |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
MED |
Subject category code subdivision |
044000 |
Source |
bisacsh |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.07/9 |
Edition number |
23 |
049 ## - LOCAL HOLDINGS (OCLC) |
Holding library |
MAIN |
245 00 - TITLE STATEMENT |
Title |
Autoantibodies : |
Remainder of title |
detection, pathogenicity, and health implications / |
Statement of responsibility, etc |
Graham E. Jenkins and Joanne I. Hall, editors. |
264 #1 - |
-- |
[Hauppauge] New York : |
-- |
Nova Science Publishers, Incorporated, |
-- |
[2012] |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource |
336 ## - |
-- |
text |
-- |
txt |
-- |
rdacontent |
337 ## - |
-- |
computer |
-- |
c |
-- |
rdamedia |
338 ## - |
-- |
online resource |
-- |
cr |
-- |
rdacarrier |
490 1# - SERIES STATEMENT |
Series statement |
Immunology and immune system disorders |
490 1# - SERIES STATEMENT |
Series statement |
Public health in the 21st century |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc |
Includes bibliographical references and index. |
588 0# - |
-- |
Print version record and CIP data provided by publisher. |
546 ## - LANGUAGE NOTE |
Language note |
English. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; AUTOANTIBODIES DETECTION, PATHOGENICITY AND HEALTH IMPLICATIONS ; CONTENTS ; PREFACE ; IMPLICATED AUTOANTIBODIES IN A KIDNEY DISEASE ; ABBREVIATIONS ; ADDITIONAL WELL KNOWN ABBREVIATIONS ; ABSTRACT ; INTRODUCTION ; AUTOIMMUNITY ; DETECTION OF AABS IN THE CIRCULATION AND IN SITU PATHOGENIC AAB RESPONSE AGAINST TARGET ANTIGENIC SITES IN THE KIDNEYS OF SPHN RATS ; PATHOGENICITY OF IGG AABS AGAINST KIDNEY AGS IN SPHN ; NON-PATHOGENIC IGM AABS AGAINST KIDNEY AGS IN SPHN ; HEALTH IMPLICATIONS. |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
PREVENTION AND TREATMENT OF A PATHOGENIC IGG AAB INITIATED AND MAINTAINED EXPERIMENTAL AUTOIMMUNE DISEASE BY THE MODIFIED VACCINATION TECHNIQUE (MVT) CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; ANTI-FACTOR H AUTOANTIBODIES IN KIDNEY DISEASE: DETECTION, PATHOGENIC ROLE AND RELEVANCE FOR TREATMENT; ABSTRACT ; INTRODUCTION ; FACTOR H; ANTI-FACTOR H AUTOANTIBODIES; Anti-Factor H Autoantibodies in Atypical Hemolytic Uremic Syndrome ; Anti-Factor H Autoantibodies in Dense Deposit Disease ; Anti-Factor H Autoantibodies in other Diseases ; DETECTION OF ANTI-FACTOR H AUTOANTIBODIES. |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
ARE ANTI-FACTOR H AUTOANTIBODIES PATHOGENIC? RELEVANCE OF THE AUTOANTIBODIES TO TREATMENT ; CONCLUSION ; ACKNOWLEDGMENTS ; REFERENCES ; AUTOANTIBODIES IN ALZHEIMER'S DISEASE ; ABSTRACT ; INTRODUCTION ; THE BLOOD-BRAIN-BARRIER (BBB): CONNECTION TO THE AD AUTOIMMUNITY HYPOTHESIS; AUTOANTIBODIES AGAINST AB PEPTIDES ; AUTOANTIBODIES AGAINST ATP SYNTHASE ; REDOX REACTIVE AUTOANTIBODIES ; AUTOANTIBODIES AGAINST NICOTINIC ACETYLOCHOLINE RECEPTORS ; AUTOANTIBODIES AGAINST GANGLIOSIDE GM1 ; AUTOANTIBODIES AGAINST OXIDIZED LOW-DENSITY LIPOPROTEIN. |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
AUTOANTIBODIES AGAINST SERINE/ARGININE PROTEIN KINASE 1 AUTOANTIBODY PROFILES IN HUMAN SERA ; CONCLUSION ; ACKNOWLEDGMENTS; REFERENCES; AUTOIMMUNITY IN CARDIOVASCULAR DISEASE; ABSTRACT ; COMMON ABBREVIATIONS USED IN THIS TEXT ; 1.0. DEFINITION OF AUTOIMMUNITY ; 2.0. CLINICAL SIGNIFICANCE OF DILATED CARDIOMYOPATHY AND PREECLAMPSIA ; 2.1. Dilated Cardiomyopathy Characteristics and Prevalence ; 2.2. Preeclampsia Characteristics and Prevalence ; 3.0. DILATED CARDIOMYOPATHY AUTOANTIBODY IMPORTANCE ; 3.1. Ý1-Adrenergic Receptor Agonistic Autoantibody (Ý1R-AA) |
505 8# - FORMATTED CONTENTS NOTE |
Formatted contents note |
3.2. Muscarinic M2 Receptor Agonistic Autoantibody (M2R-AA) 3.3. Clinical Significance ; 4.0. AUTOANTIBODY AND SIGNIFICANCE IN PREECLAMPSIA ; 4.1. In Vitro Studies of PE ; 4.2. Effects of PE in Various Laboratory and Clinical Settings ; A. Mouse Studies with Adoptive Transfer ; B. Rat Studies with Adoptive Transfer ; C. Human Evidence Supporting Autoantibody Role in PE ; 5.0. AUTOANTIBODY RECEPTOR BINDING AND PRODUCTION ; 5.1. Mechanisms Underlying Ý1R-AA Production ; 5.2. Mechanisms Underlying AT1-AA Production and Function; 6.0. THERAPEUTIC CONSIDERATIONS. |
590 ## - LOCAL NOTE (RLIN) |
Local note |
eBooks on EBSCOhost |
Provenance (VM) [OBSOLETE] |
EBSCO eBook Subscription Academic Collection - Worldwide |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoantibodies. |
9 (RLIN) |
367433 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoantibodies |
General subdivision |
Analysis. |
9 (RLIN) |
1258790 |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoimmunity. |
9 (RLIN) |
185776 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoantibodies |
9 (RLIN) |
367433 |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoimmunity |
9 (RLIN) |
185776 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoanticorps. |
9 (RLIN) |
1007192 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoanticorps |
General subdivision |
Analyse. |
9 (RLIN) |
1258791 |
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Auto-immunité. |
9 (RLIN) |
899804 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
MEDICAL |
General subdivision |
Immunology. |
Source of heading or term |
bisacsh |
9 (RLIN) |
899805 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoantibodies. |
Source of heading or term |
fast |
-- |
(OCoLC)fst00822532 |
9 (RLIN) |
367433 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoantibodies |
General subdivision |
Analysis. |
Source of heading or term |
fast |
-- |
(OCoLC)fst00822533 |
9 (RLIN) |
1258790 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Autoimmunity. |
Source of heading or term |
fast |
-- |
(OCoLC)fst00822674 |
9 (RLIN) |
185776 |
655 #0 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books. |
655 #4 - INDEX TERM--GENRE/FORM |
Genre/form data or focus term |
Electronic books. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Jenkins, Graham E., |
Relator term |
editor. |
9 (RLIN) |
1258792 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Hall, Joanne I., |
Relator term |
editor. |
9 (RLIN) |
1258793 |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Display text |
Print version: |
Title |
Autoantibodies. |
Place, publisher, and date of publication |
[Hauppauge] New York : Nova Science Publishers, Inc., [2012] |
International Standard Book Number |
9781620815601 |
Record control number |
(DLC) 2012935164 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Immunology and immune system disorders. |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE |
Uniform title |
Public health in the 21st century series. |
9 (RLIN) |
864838 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
<a href="https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541271">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=541271</a> |
938 ## - |
-- |
ProQuest Ebook Central |
-- |
EBLB |
-- |
EBL3020980 |
938 ## - |
-- |
ebrary |
-- |
EBRY |
-- |
ebr10681180 |
938 ## - |
-- |
EBSCOhost |
-- |
EBSC |
-- |
541271 |
938 ## - |
-- |
YBP Library Services |
-- |
YANK |
-- |
9371477 |
994 ## - |
-- |
92 |
-- |
INOPJ |